Sarepta Therapeutics, Inc. (SRPT) financial statements (2022 and earlier)

Company profile

Business Address 215 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:2,1261,9481,1341,1751,090329204
Cash and cash equivalents2,1161,50383537160012280
Short-term investments 436290803479195112
Other undisclosed cash, cash equivalents, and short-term investments109101111112
Restricted cash and investments     1111
Receivables15310191492954
Inventory, net of allowances, customer advances and progress billings1862321711258413 
Inventory1862321711258413 
Other current assets1492138278372717
Other undisclosed current assets(10)(9)(10)(1)(11)(11)(12)
Total current assets:2,6042,4851,4691,4261,229373225
Noncurrent Assets
Operating lease, right-of-use asset469238
Property, plant and equipment19119013097433837
Long-term investments and receivables    10  
Long-term investments    10  
Intangible assets, net (including goodwill)141412121487
Intangible assets, net (excluding goodwill)141412121487
Prepaid expense   87  
Regulated entity, other noncurrent assets    1  
Deposits noncurrent assets   63   
Restricted cash and investments   1111
Other noncurrent assets293204174  44
Other undisclosed noncurrent assets   363  
Total noncurrent assets:544500354216795149
TOTAL ASSETS:3,1482,9851,8231,6421,308424274
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities348305254168776149
Accounts payable77111683483020
Accrued liabilities272194186134693129
Deferred revenue8989 
Debt    6108
Deferred revenue and credits333
Contract with customer, liability3
Other liabilities1522112111
Total current liabilities:453416265174887562
Noncurrent Liabilities
Long-term debt and lease obligation1,1381,073730421425615
Long-term debt, excluding current maturities1,097992682421425615
Operating lease, liability428048
Liabilities, other than long-term debt5856831016666
Deferred revenue574663 
Other liabilities11201016666
Other undisclosed noncurrent liabilities4451     
Total noncurrent liabilities:1,7671,8077404364301221
Total liabilities:2,2202,2231,0056105198783
Stockholders' equity
Stockholders' equity attributable to parent, including:9287628181,032789337190
Common stock0000000
Additional paid in capital4,1353,6103,1122,6112,0071,5031,090
Accumulated other comprehensive income (loss)000(0)(0)(0)(0)
Accumulated deficit(3,207)(2,848)(2,294)(1,579)(1,217)(1,166)(899)
Other undisclosed stockholders' equity attributable to parent(0)      
Total stockholders' equity:9287628181,032789337190
TOTAL LIABILITIES AND EQUITY:3,1482,9851,8231,6421,308424274

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues70254038130115551
Revenue, net15551
Cost of revenue(205)(171)(67)(30)(32)(0) 
Cost of goods and services sold     (0) 
Gross profit:49736931427112351
Operating expenses(957)(933)(1,020)(614)(294)(272)(221)
Operating loss:(460)(564)(706)(344)(172)(267)(220)
Nonoperating income (expense)4111(8)(19)123(1)0
Investment income, nonoperating03772  
Other nonoperating income (expense)(1)1(0)(1)(2)(1)0
Interest and debt expense(64)(60)(31)(2)(6)  
Loss from continuing operations before equity method investments, income taxes:(482)(613)(745)(365)(54)(267)(220)
Other undisclosed income from continuing operations before income taxes64603126  
Loss from continuing operations before income taxes:(419)(553)(714)(363)(49)(267)(220)
Income tax expense (benefit)0(1)(1)1(2)  
Net loss available to common stockholders, diluted:(419)(554)(715)(362)(51)(267)(220)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(419)(554)(715)(362)(51)(267)(220)
Other comprehensive income (loss)(0)(0)00(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(419)(554)(715)(362)(51)(267)(220)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: